Guardian Pharmacy (GRDN) 13G/A: J. Goldman 2.9%, 656,860 sh stake
Rhea-AI Filing Summary
J. Goldman & Co., L.P. filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of 656,860 shares of Guardian Pharmacy Services, Inc. common stock, representing 2.9% of the class as of the event date 09/30/2025.
The filing is jointly made by J. Goldman & Co., L.P., J. Goldman Capital Management, Inc., and Jay G. Goldman. Each reports 0 shares with sole voting or dispositive power and 656,860 shares with shared voting and shared dispositive power. The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership did J. Goldman report in GRDN on this Schedule 13G/A?
They reported beneficial ownership of 656,860 common shares, equal to 2.9% of the class.
Which entities and individuals are listed as reporting persons for GRDN?
J. Goldman & Co., L.P., J. Goldman Capital Management, Inc., and Jay G. Goldman.
What are the voting and dispositive powers disclosed for the GRDN position?
Each reports 0 shares with sole voting/dispositive power and 656,860 shares with shared voting/dispositive power.
What is the event date referenced in the GRDN Schedule 13G/A?
The date of event is 09/30/2025.
Does the filing indicate a passive investment intent for GRDN?
Yes. The certification states the securities were acquired and are held in the ordinary course, not to change or influence control.
What class and CUSIP does the GRDN filing cover?
It covers Common Stock with CUSIP 40145W101.